EP3565806
NÝJAR FENÝL AFLEIÐUR
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.1.2018EP published:
2.3.2022EP application number:
18709129.3
EP translation filed:
17.5.2022Grant published:
15.6.2022EPO information:
European Patent Register
Max expiry date:
4.1.2038Expiry date:
4.1.2027Next due date:
31.1.2027
Title in English:
NOVEL PHENYL DERIVATIVESLanguage of the patent:
English
Timeline
Today
5.1.2018EP application
2.3.2022EP Publication
17.5.2022Translation submitted
15.6.2022Registration published
4.1.2027Expires
Owner
Name:
Rivus Pharmaceuticals, Inc.Address:
706B Forest Street, Charlottesville, VA 22903, US
Inventor
Name:
KHAN, Shaharyar M.Address:
Charlottesville, VA 22901, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201762443244 PDate:
6.1.2017Country:
US
Number:
201762581355 PDate:
3.11.2017Country:
US
Number:
201762585326 PDate:
13.11.2017Country:
US
Classification
Categories:
C07D 233/91, A61P 3/04, A61P 9/00, A61P 3/10, A61K 31/4168
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 13.12.2022
Expires: 4.1.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 18.12.2023
Expires: 4.1.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 10.12.2024
Expires: 4.1.2026
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.1.2026
Expires: 4.1.2027
Payer: Árnason Faktor ehf.